BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aziz A, Fronczek R, Maat-Schieman M, Unmehopa U, Roelandse F, Overeem S, van Duinen S, Lammers GJ, Swaab D, Roos R. Hypocretin and melanin-concentrating hormone in patients with Huntington disease. Brain Pathol 2008;18:474-83. [PMID: 18498421 DOI: 10.1111/j.1750-3639.2008.00135.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 38] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Gabery S, Georgiou-Karistianis N, Lundh SH, Cheong RY, Churchyard A, Chua P, Stout JC, Egan GF, Kirik D, Petersén Å. Volumetric analysis of the hypothalamus in Huntington Disease using 3T MRI: the IMAGE-HD Study. PLoS One 2015;10:e0117593. [PMID: 25659157 DOI: 10.1371/journal.pone.0117593] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
2 Krolewski DM, Medina A, Kerman IA, Bernard R, Burke S, Thompson RC, Bunney WE Jr, Schatzberg AF, Myers RM, Akil H, Jones EG, Watson SJ. Expression patterns of corticotropin-releasing factor, arginine vasopressin, histidine decarboxylase, melanin-concentrating hormone, and orexin genes in the human hypothalamus. J Comp Neurol 2010;518:4591-611. [PMID: 20886624 DOI: 10.1002/cne.22480] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
3 Soylu-Kucharz R, Baldo B, Petersén Å. Metabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington's disease. Sci Rep 2016;6:28322. [PMID: 27334347 DOI: 10.1038/srep28322] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
4 Baldo B, Gabery S, Soylu-Kucharz R, Cheong RY, Henningsen JB, Englund E, McLean C, Kirik D, Halliday G, Petersén Å. SIRT1 is increased in affected brain regions and hypothalamic metabolic pathways are altered in Huntington disease. Neuropathol Appl Neurobiol 2019;45:361-79. [PMID: 30019499 DOI: 10.1111/nan.12514] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
5 Baldo B, Soylu R, Petersén A. Maintenance of basal levels of autophagy in Huntington's disease mouse models displaying metabolic dysfunction. PLoS One 2013;8:e83050. [PMID: 24376631 DOI: 10.1371/journal.pone.0083050] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
6 Fronczek R, Baumann CR, Lammers GJ, Bassetti CL, Overeem S. Hypocretin/orexin disturbances in neurological disorders. Sleep Medicine Reviews 2009;13:9-22. [DOI: 10.1016/j.smrv.2008.05.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
7 Liu F, Chang HC. Physiological links of circadian clock and biological clock of aging. Protein Cell 2017;8:477-88. [PMID: 28108951 DOI: 10.1007/s13238-016-0366-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
8 Heese K. G proteins, p60TRP, and neurodegenerative diseases. Mol Neurobiol 2013;47:1103-11. [PMID: 23345134 DOI: 10.1007/s12035-013-8410-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
9 van Wamelen DJ, Shan L, Aziz NA, Anink JJ, Bao AM, Roos RA, Swaab DF. Functional increase of brain histaminergic signaling in Huntington's disease. Brain Pathol 2011;21:419-27. [PMID: 21106039 DOI: 10.1111/j.1750-3639.2010.00465.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
10 Soneson C, Fontes M, Zhou Y, Denisov V, Paulsen JS, Kirik D, Petersén A; Huntington Study Group PREDICT-HD investigators. Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis. Neurobiol Dis 2010;40:531-43. [PMID: 20682340 DOI: 10.1016/j.nbd.2010.07.013] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
11 Alpár A, Harkany T. Orexin neurons use endocannabinoids to break obesity-induced inhibition. Proc Natl Acad Sci U S A 2013;110:9625-6. [PMID: 23720305 DOI: 10.1073/pnas.1307389110] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
12 Henningsen JB, Soylu-Kucharz R, Björkqvist M, Petersén Å. Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease. Heliyon 2021;7:e07808. [PMID: 34458633 DOI: 10.1016/j.heliyon.2021.e07808] [Reference Citation Analysis]
13 Torterolo P, Lagos P, Monti JM. Melanin-concentrating hormone: a new sleep factor? Front Neurol 2011;2:14. [PMID: 21516258 DOI: 10.3389/fneur.2011.00014] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 4.5] [Reference Citation Analysis]
14 Aziz NA, van der Marck MA, Pijl H, Olde Rikkert MG, Bloem BR, Roos RA. Weight loss in neurodegenerative disorders. J Neurol 2008;255:1872-80. [PMID: 19165531 DOI: 10.1007/s00415-009-0062-8] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 5.8] [Reference Citation Analysis]
15 Silajdžić E, Björkqvist M. A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward. J Huntingtons Dis 2018;7:109-35. [PMID: 29614689 DOI: 10.3233/JHD-170273] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
16 Zhang Y, Ren R, Yang L, Zhou J, Li Y, Shi J, Lu L, Sanford LD, Tang X. Sleep in Huntington's disease: a systematic review and meta-analysis of polysomongraphic findings. Sleep 2019;42:zsz154. [PMID: 31328779 DOI: 10.1093/sleep/zsz154] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
17 Shan L, Dauvilliers Y, Siegel JM. Interactions of the histamine and hypocretin systems in CNS disorders. Nat Rev Neurol 2015;11:401-13. [PMID: 26100750 DOI: 10.1038/nrneurol.2015.99] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 8.0] [Reference Citation Analysis]
18 Cheong RY, Gabery S, Petersén Å. The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease. J Huntingtons Dis 2019;8:375-91. [PMID: 31594240 DOI: 10.3233/JHD-190372] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
19 Cheong RY, Baldo B, Sajjad MU, Kirik D, Petersén Å. Effects of mutant huntingtin inactivation on Huntington disease-related behaviours in the BACHD mouse model. Neuropathol Appl Neurobiol 2021;47:564-78. [PMID: 33330988 DOI: 10.1111/nan.12682] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Diniz GB, Bittencourt JC. The Melanin-Concentrating Hormone (MCH) System: A Tale of Two Peptides. Front Neurosci 2019;13:1280. [PMID: 31849590 DOI: 10.3389/fnins.2019.01280] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
21 Mattis J, Sehgal A. Circadian Rhythms, Sleep, and Disorders of Aging. Trends Endocrinol Metab 2016;27:192-203. [PMID: 26947521 DOI: 10.1016/j.tem.2016.02.003] [Cited by in Crossref: 140] [Cited by in F6Publishing: 116] [Article Influence: 23.3] [Reference Citation Analysis]
22 Goodman AOG, Barker RA. How vital is sleep in Huntington’s disease? J Neurol 2010;257:882-97. [DOI: 10.1007/s00415-010-5517-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
23 Voysey Z, Fazal SV, Lazar AS, Barker RA. The sleep and circadian problems of Huntington's disease: when, why and their importance. J Neurol 2021;268:2275-83. [PMID: 33355880 DOI: 10.1007/s00415-020-10334-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Bartlett DM, Domínguez D JF, Reyes A, Zaenker P, Feindel KW, Newton RU, Hannan AJ, Slater JA, Eastwood PR, Lazar AS, Ziman M, Cruickshank T. Investigating the relationships between hypothalamic volume and measures of circadian rhythm and habitual sleep in premanifest Huntington's disease. Neurobiol Sleep Circadian Rhythms 2019;6:1-8. [PMID: 31236517 DOI: 10.1016/j.nbscr.2018.07.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
25 Ma L, Herren AW, Espinal G, Randol J, McLaughlin B, Martinez-Cerdeño V, Pessah IN, Hagerman RJ, Hagerman PJ. Composition of the Intranuclear Inclusions of Fragile X-associated Tremor/Ataxia Syndrome. Acta Neuropathol Commun 2019;7:143. [PMID: 31481131 DOI: 10.1186/s40478-019-0796-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
26 Yan L, Lonstein JS, Nunez AA. Light as a modulator of emotion and cognition: Lessons learned from studying a diurnal rodent. Horm Behav 2019;111:78-86. [PMID: 30244030 DOI: 10.1016/j.yhbeh.2018.09.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
27 Morairty SR, Wisor J, Silveira K, Sinko W, Kilduff TS. The wake-promoting effects of hypocretin-1 are attenuated in old rats. Neurobiol Aging 2011;32:1514-27. [PMID: 19781813 DOI: 10.1016/j.neurobiolaging.2009.07.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
28 Aziz NA, Pijl H, Frölich M, Schröder-van der Elst JP, van der Bent C, Roelfsema F, Roos RA. Delayed onset of the diurnal melatonin rise in patients with Huntington's disease. J Neurol 2009;256:1961-5. [PMID: 19562249 DOI: 10.1007/s00415-009-5196-1] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 5.5] [Reference Citation Analysis]
29 Schneider WT, Vas S, Nicol AU, Morton AJ. Abnormally abrupt transitions from sleep-to-wake in Huntington's disease sheep (Ovis aries) are revealed by automated analysis of sleep/wake transition dynamics. PLoS One 2021;16:e0251767. [PMID: 33984047 DOI: 10.1371/journal.pone.0251767] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Wamelen DJV, Aziz NA, Zhao J, Balesar R, Unmehopa U, Roos RA, Swaab DF. Decreased Hypothalamic Prohormone Convertase Expression in Huntington Disease Patients. J Neuropathol Exp Neurol 2013;72:1126-34. [DOI: 10.1097/nen.0000000000000010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
31 Oh ST, Liu QF, Jeong HJ, Lee S, Samidurai M, Jo J, Pak SC, Park HJ, Kim J, Jeon S. Nasal Cavity Administration of Melanin-Concentrating Hormone Improves Memory Impairment in Memory-Impaired and Alzheimer's Disease Mouse Models. Mol Neurobiol 2019;56:8076-86. [PMID: 31183806 DOI: 10.1007/s12035-019-01662-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
32 van Wamelen DJ, Aziz NA, Anink JJ, van Steenhoven R, Angeloni D, Fraschini F, Jockers R, Roos RA, Swaab DF. Suprachiasmatic nucleus neuropeptide expression in patients with Huntington's Disease. Sleep 2013;36:117-25. [PMID: 23288978 DOI: 10.5665/sleep.2314] [Cited by in Crossref: 3] [Cited by in F6Publishing: 24] [Article Influence: 0.3] [Reference Citation Analysis]
33 Naidoo N, Zhu J, Zhu Y, Fenik P, Lian J, Galante R, Veasey S. Endoplasmic reticulum stress in wake-active neurons progresses with aging. Aging Cell 2011;10:640-9. [PMID: 21388495 DOI: 10.1111/j.1474-9726.2011.00699.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
34 van Wamelen DJ, Aziz NA, Anink JJ, Roos RA, Swaab DF. Paraventricular nucleus neuropeptide expression in Huntington's disease patients. Brain Pathol 2012;22:654-61. [PMID: 22257050 DOI: 10.1111/j.1750-3639.2012.00565.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
35 Brown JA, Woodworth HL, Leinninger GM. To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance. Front Syst Neurosci 2015;9:9. [PMID: 25741247 DOI: 10.3389/fnsys.2015.00009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
36 Vercruysse P, Vieau D, Blum D, Petersén Å, Dupuis L. Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism. Front Mol Neurosci 2018;11:2. [PMID: 29403354 DOI: 10.3389/fnmol.2018.00002] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 14.3] [Reference Citation Analysis]
37 Sousa-Ferreira L, Álvaro AR, Aveleira C, Santana M, Brandão I, Kügler S, de Almeida LP, Cavadas C. Proliferative hypothalamic neurospheres express NPY, AGRP, POMC, CART and Orexin-A and differentiate to functional neurons. PLoS One 2011;6:e19745. [PMID: 21589937 DOI: 10.1371/journal.pone.0019745] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
38 Baldo B, Cheong RY, Petersén Å. Effects of deletion of mutant huntingtin in steroidogenic factor 1 neurons on the psychiatric and metabolic phenotype in the BACHD mouse model of Huntington disease. PLoS One 2014;9:e107691. [PMID: 25271967 DOI: 10.1371/journal.pone.0107691] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]